Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study

被引:0
|
作者
Dorinde M. van Andel
Jan J. Sprengers
Bob Oranje
Floortje E. Scheepers
Floor E. Jansen
Hilgo Bruining
机构
[1] University Medical Center Utrecht,Department of Psychiatry, Brain Center
[2] University Medical Center Utrecht,Department of Pediatric Neurology, Brain Center
[3] University of Amsterdam,Department of Child and Adolescent Psychiatry, Amsterdam UMC
来源
关键词
Tuberous sclerosis complex; Bumetanide; Open-label; NKCC1 antagonist; TAND; Irritability; ERP; Neurocognitive task;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis.
    Denton, Christopher P.
    Engelhart, Merete
    Tvede, N.
    Khan, Korsa
    Carreire, Patricia E.
    Gonzalez, F. Diaz
    Van den Hoogen, Frank H.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S524 - S524
  • [22] Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study
    Franz, David Neal
    Belousova, Elena
    Sparagana, Steven
    Bebin, E. Martina
    Frost, Michael
    Kuperman, Rachel
    Witt, Olaf
    Kohrman, Michael H.
    Flamini, J. Robert
    Wu, Joyce Y.
    Curatolo, Paolo
    de Vries, Petrus J.
    Berkowitz, Noah
    Anak, Oezlem
    Niolat, Julie
    Jozwiak, Sergiusz
    LANCET ONCOLOGY, 2014, 15 (13): : 1513 - 1520
  • [23] Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients
    Paik, Julie J.
    Casciola-Rosen, Livia
    Shin, Joseph Yusup
    Albayda, Jemima
    Tiniakou, Eleni
    Leung, Doris G.
    Gutierrez-Alamillo, Laura
    Perin, Jamie
    Florea, Liliana
    Antonescu, Corina
    Leung, Sherry G.
    Purwin, Grazyna
    Koenig, Andrew
    Christopher-Stine, Lisa
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 875 - 884
  • [24] An Open-Label Observational Pilot Study To Evaluate the Safety and Immunogenicity of the Herpes Zoster Vaccine in Patients with Multiple Sclerosis
    McGraw, Corey
    Inglese, Matilde
    Petracca, Maria
    Hannigan, Christine
    Miller, Aaron
    NEUROLOGY, 2013, 80
  • [25] An open-label observational pilot study to evaluate the safety and immunogenicity of the herpes zoster vaccine in patients with multiple sclerosis
    McGraw, C.
    Inglese, M.
    Hannigan, C.
    Petracca, M.
    Miller, A.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 143 - 143
  • [26] Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study
    Gupta, Ajay
    de Bruyn, Gwendolyn
    Tousseyn, Simon
    Krishnan, Balu
    Lagae, Lieven
    Agarwal, Nitin
    PEDIATRIC NEUROLOGY, 2020, 106 : 10 - 16
  • [27] The Effects of Individual Upper Alpha Neurofeedback in ADHD: An Open-Label Pilot Study
    Escolano, C.
    Navarro-Gil, M.
    Garcia-Campayo, J.
    Congedo, M.
    Minguez, J.
    APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK, 2014, 39 (3-4) : 193 - 202
  • [28] The Effects of QEEG-Informed Neurofeedback in ADHD: An Open-Label Pilot Study
    Arns, Martijn
    Drinkenburg, Wilhelmus
    Kenemans, J. Leon
    APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK, 2012, 37 (03) : 171 - 180
  • [29] The Effects of QEEG-Informed Neurofeedback in ADHD: An Open-Label Pilot Study
    Martijn Arns
    Wilhelmus Drinkenburg
    J. Leon Kenemans
    Applied Psychophysiology and Biofeedback, 2012, 37 : 171 - 180
  • [30] Effects of ketanserin on microcirculatory alterations in septic shock: An open-label pilot study
    Vellinga, Namkje A. R.
    Veenstra, Gerke
    Scorcella, Claudia
    Koopmans, Matty
    van Roon, Eric N.
    Ince, Can
    Boerma, E. Christiaan
    JOURNAL OF CRITICAL CARE, 2015, 30 (06) : 1156 - 1162